Abdelaziz, G., Elsafi, O., Abdel Fattah, N., Abdelazeem, M. (2023). Evaluation of Psychosocial Morbidity among Children and Adolescents with Beta-Thalassemia Major. The Egyptian Journal of Hospital Medicine, 90(2), 2526-2533. doi: 10.21608/ejhm.2023.286036
Ghada Abdelaziz Mohamed Abdelaziz; Osama Roshdy Elsafi; Nelly R. Abdel Fattah; Mahmoud Abdelazeem. "Evaluation of Psychosocial Morbidity among Children and Adolescents with Beta-Thalassemia Major". The Egyptian Journal of Hospital Medicine, 90, 2, 2023, 2526-2533. doi: 10.21608/ejhm.2023.286036
Abdelaziz, G., Elsafi, O., Abdel Fattah, N., Abdelazeem, M. (2023). 'Evaluation of Psychosocial Morbidity among Children and Adolescents with Beta-Thalassemia Major', The Egyptian Journal of Hospital Medicine, 90(2), pp. 2526-2533. doi: 10.21608/ejhm.2023.286036
Abdelaziz, G., Elsafi, O., Abdel Fattah, N., Abdelazeem, M. Evaluation of Psychosocial Morbidity among Children and Adolescents with Beta-Thalassemia Major. The Egyptian Journal of Hospital Medicine, 2023; 90(2): 2526-2533. doi: 10.21608/ejhm.2023.286036
Evaluation of Psychosocial Morbidity among Children and Adolescents with Beta-Thalassemia Major
Background: Thalassemia major (TM) is a long-term illness that affects the child and family emotionally and psychologically. Aim: To assess the existence of psychiatric symptoms in thalassemia-affected children and teenagers, such as hysteria, somatic symptoms, obsessive symptoms, depressive symptoms, anxiety, and phobic anxiety. Subjects and methods: This is a case-control study that included 42 children and adolescents who have transfusion-dependent beta-thalassemia major and 42 healthy controls. All patients underwent Psychological assessment using a questionnaireby The Arabic version of the Child Behavior Check List (CBCL/6-18). Results: There was a significant difference between the two groups regarding total problems grades that were clinical and borderline in cases more than in the control group. Conclusion: The Arabic version of the Child Behavior Check List identifies behavioral and psychological issues in patients with beta-thalassemia major.